Oct 28 – The Dutch government on Wednesday ordered farmers across the country to keep poultry indoors following three reported birdflu outbreaks in recent days. “The risk of further infections is significant. To prevent as much suffering as possible for both animals and business owners, I have decid
By Abigail Summerville NEW YORK, Oct 28 (Reuters) – Rho Nutrition, a maker of liquid supplements and vitamins, is exploring a sale that could value the company at over $500 million, according to three people familiar with the matter. The privately held company is working with investment bank Roths
By Olivia Le Poidevin GENEVA, Oct 28 (Reuters) – The Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed American physician Mark Dybul as the organization’s next Executive Director, it said in a statement on Wednesday. • Dybul returns to the organization early next year af
Oct 28 (Reuters) – IAVI, a biomedical research organization, said on Wednesday it was awarded $36 million under a US government contract worth up to $99 million to advance development of its single-dose vaccine candidate against the Bundibugyo strain of the Ebola virus. The number of confirmed Ebola
By Christy Santhosh Oct 28 (Reuters) – Geron said on Wednesday it would halt a late-stage trial of its blood cancer treatment, marking a setback for the company’s only commercial product, sending its shares plunging 20% in early trading. The drug, branded as Rytelo, was being evaluated as a treatmen
By Nancy Lapid Oct 28 (Reuters) – With wildfires becoming larger and more prevalent, today we report on a study that suggests a link between exposure during pregnancy to harmful particles in smoke from the infernos and autism in the women’s children. Speaking of harmful particles, we also feature a
By Sriparna Roy Oct 28 (Reuters) – Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, outperformed Novo Nordisk’s Ozempic on blood sugar control and delivered more than double the weight loss in a diabetes study. The data strengthens the competitive profile of re
By Christy Santhosh Oct 28 (Reuters) – Biogen beat Wall Street estimates for third-quarter results on Wednesday, as robust demand for its rare-disease and Alzheimer’s treatments helped offset declines in its under-pressure multiple sclerosis franchise. The US drugmaker deepened its bets on rare dise
By Pushkala Aripaka Oct 28 (Reuters) – GSK investors punished the British drugmaker on Wednesday despite a third-quarter sales and profit beat, focusing instead on questions over its drug pipeline and weak sales of vaccines, including its shingles shot Shingrix. The company’s London-listed shares we
By Cian Muenster and Isabela Kruczynska Oct 28 (Reuters) – Swiss dental implants maker Straumann reported third-quarter sales slightly above expectations on Wednesday, helped by new product launches and growth across its main regions. Investors are closely watching Straumann’s performance in North A
By Siddhi Mahatole Oct 27 (Reuters) – Cooper Companies said on Tuesday CEO Al White had stepped down, effective immediately, and board member Walt Rosebrough was elected executive chair as the medical device maker begins its search for a new CEO. • Rosebrough, an independent director who joined the
Oct 27 (Reuters) – Eli Lilly said on Tuesday that Patrik Jonsson, executive vice president and president of its international business, will retire at the end of 2026 after a 36-year career at the US drugmaker. The company said Ilya Yuffa will become executive vice president and president of the new
Oct 27 (Reuters) – The US FDA has warned Amgen that a promotional video for its colorectal cancer drug was misleading because it highlighted the benefits while failing to adequately disclose serious safety risks and patient limitations, according to an update posted on the agency’s website on Tuesda
COPENHAGEN, Oct 27 (Reuters) – Bavarian Nordic will donate vaccines for a global mpox emergency stockpile to strengthen preparedness against the viral disease, the Danish vaccine maker said in a statement on Tuesday. • Bavarian Nordic will donate 75,000 doses of its MVA-BN vaccine to the emergency s
By Maria Cheng OTTAWA, Oct 27 (Reuters) – The Canadian government will introduce a new bill on Tuesday to allow people to request being euthanized at a later date when they have lost the mental capacity to make that decision, in a potential further expansion of one of the world’s most liberal assist
ZURICH, Oct 27 (Reuters) – Swiss AI start-up Atlast Bio, which runs drug trials on virtual patients, has received $12.5 million in funding led by Swedish venture capital firm Creandum, an early backer of Spotify and Trade Republic, the company said on Tuesday. • Atlas Bio is aiming to replace Phase
Oct 27 (Reuters) – Indian pharmacy chain MedPlus Health Services reported a slight increase in second-quarter profit on Tuesday, helped by higher demand at its retail unit and store network expansion. Here are some more details: • The company reported a consolidated net profit of 560.8 million rupee
Oct 27 (Reuters) – Artiva Biotherapeutics said on Tuesday it would halt the development of an experimental cell therapy for certain autoimmune conditions — its lead candidate — after two patient deaths, sending its shares slumping 32%. The company will slash its workforce by about 94% and evaluate s
By Joshua McElwee VATICAN CITY, Oct 27 (Reuters) – Since undergoing surgery on October 13 to treat lung cancer, Pope Leo has weighed a major decision: whether to press ahead with an intense, three-country tour of South America just 24 days after having part of one lung removed. But in the end, accor
By Sahil Pandey and Kamal Choudhury Oct 27 (Reuters) – US hospital operator HCA Healthcare signaled flat earnings for 2027 on Tuesday, as lower Medicaid payments and a rise in uninsured patients threaten to offset steady patient demand, sending its shares down over 5%. On a post-earnings conference
By Sneha S K and Padmanabhan Ananthan Oct 27 (Reuters) – Centene raised its annual profit forecast and said it expects 2027 earnings to be higher than this year, sending the health insurer’s shares up 3%. Higher medical costs in recent years due to elevated healthcare demand have squeezed margins fo
BEIJING, Oct 27 (Reuters) – Jiangsu Hengrui Pharmaceuticals, China’s biggest drugmaker by market value, reported on Tuesday a rise of 88.9% in profit for the third quarter of 2026, driven by income from out-licensing deals. • Net profit of 2.5 billion yuan ($375 million) for the quarter ended Septe
Oct 27 (Reuters) – The number of confirmed Ebola cases in Democratic Republic of Congo has risen above 10,000, government data showed on Tuesday, a milestone that coincides with growing fears the epidemic could spread to more African countries. The latest situation report from Congo’s public health
By Kashish Tandon Oct 27 (Reuters) – Indian drugmaker Cipla missed second-quarter profit estimates on Tuesday as a sharp slowdown in its US business eclipsed strong growth at home. The country’s third-largest drugmaker by revenue is experiencing weakness in North America, its biggest overseas market
Oct 27 (Reuters) – GSK expects to nearly double the number of cancer medicines it is testing in clinical trials next year, the Wall Street Journal reported on Tuesday, citing an interview with a scientist at the British drugmaker. • Hesham Abdullah, GSK’s head of oncology research and development, t
By Alexander Marrow LONDON, Oct 27 (Reuters) – Dettol maker Reckitt lowered its annual revenue forecast on Tuesday and reported revenue growth below analyst expectations in the third quarter, hampered by a challenging consumer environment and manufacturing constraints in its North American market. T
By Patricia Weiss, Bhanvi Satija and Marleen Kaesebier ZURICH/LONDON, Oct 27 (Reuters) – Novartis recorded about $2.2 billion in charges related to two drugs that failed in late-stage studies last month, even as it boosted its full-year profit expectations on Tuesday. The Swiss drugmaker’s operating
By Jonathan Stempel Oct 26 (Reuters) – A US judge rejected on Monday Novo Nordisk’s request to block Eli Lilly from continuing advertisements for weight-loss drugs that the Danish drugmaker considered false and misleading, affecting markets with tens of billions of dollars of annual sales. US Distri
Oct 26 (Reuters) – Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that have tapped the fall IPO window. The sector has been a bright spot in an otherwise lackluster fall
Oct 26 (Reuters) – The Pennsylvania Health Department on Monday reported 1,360 measles cases in the state, up 22 cases from its previous update. Here are key details: • Measles-related hospitalizations this year stand at 258 as of October 26, according to state health department data • The Pennsylva
